Kaupke C J
Division of Nephrology and Hypertension, University of California, Irvine, Orange, USA.
Clin Cardiol. 1995 Jun;18(6 Suppl 3):III 17-22. doi: 10.1002/clc.4960181505.
Various antihypertensive agents may reduce blood pressure to a similar degree, yet they produce different outcomes with respect to long-term end-organ damage. Effective antihypertensive therapy can prevent or even reverse established left ventricular hypertrophy. The most rapid and extensive regression occurs with agents that block the reninangiotensin system or reduce entry of calcium into the cells. Other classes of drugs that reliably reverse left ventricular hypertrophy are centrally acting adrenergic inhibitors and beta blockers. The effect of antihypertensive agents on atherosclerosis appears to differ widely with regard to lipid metabolism, insulin sensitivity, and the biology of endothelium and vascular smooth muscle. Hypertension and chronic renal failure (diabetic and nondiabetic) are closely allied, but available antihypertensive agents are not equally potent in reducing intraglomerular pressure.
各种抗高血压药物可能在相似程度上降低血压,但就长期终末器官损害而言,它们会产生不同的结果。有效的抗高血压治疗可以预防甚至逆转已形成的左心室肥厚。阻断肾素 - 血管紧张素系统或减少钙进入细胞的药物会出现最迅速且广泛的逆转。其他能可靠地逆转左心室肥厚的药物类别是中枢性作用的肾上腺素能抑制剂和β受体阻滞剂。抗高血压药物对动脉粥样硬化的影响在脂质代谢、胰岛素敏感性以及内皮和血管平滑肌生物学方面似乎差异很大。高血压与慢性肾衰竭(糖尿病性和非糖尿病性)密切相关,但现有的抗高血压药物在降低肾小球内压力方面的效力并不相同。